- Raised $150k grant, May 2024
- Raised $600k grant led by Israel Innovation Authority , May 2024
- Raised $375k funding round, Feb 2022
About
AccuLine was founded with the vision to save the lives of millions of people worldwide by preventing the next heart attack. AccuLine is developing CORA – an accurate, non-invasive, swift, and cost-effective examination for early detection of CAD, designed to replace the inaccurate, time-consuming, and labor-intensive stress test examinations.
Through a brief 4-minute evaluation of three vital signs - the heart's electrical activity, oxygen saturation levels, and respiratory phase, CORA automatically generates results, ensuring a seamless and efficient process. CORA has the potential to save the lives of millions of patients worldwide, while simultaneously decreasing health care-related costs.
AccuLine has received grants from Google and the Israeli Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
Funding history · 5 rounds · $6.3M total
Q&A
- What is AccuLine's primary mission?
- AccuLine's primary mission is to save lives by preventing heart attacks through the early detection of Coronary Artery Disease (CAD).
- What product is AccuLine developing?
- AccuLine is developing CORA, a non-invasive, swift, and cost-effective examination for the early detection of CAD, designed to replace traditional stress tests.
- How does CORA work?
- CORA evaluates three vital signs—the heart's electrical activity, oxygen saturation levels, and respiratory phase—in a brief 4-minute examination to automatically generate results.
- When was AccuLine founded?
- AccuLine was founded in February 2022.
- What is the total amount of funding AccuLine has raised to date?
- AccuLine has raised a total of $6,255,000 USD.
- Which investors participated in AccuLine's funding rounds?
- Key investors and grant providers include eHealth Ventures and Maccabi Healthcare Services
- When did AccuLine receive its most recent grant?
- AccuLine received grants from the Israel Innovation Authority and Google in May 2024.
- What is AccuLine's current product stage?
- AccuLine's product is currently in the clinical trial stage.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | acculine-medical.com |
|---|---|
| linkedin.com/company/82039359 |
Identifiers & details
| Founded | 2022-2 |
|---|---|
| Employees (exact) | 12 |
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | acculine-medical.com |
|---|